Učitavanje...
Safety of vedolizumab in liver transplant recipients: A systematic review
BACKGROUND: The management of inflammatory bowel disease in patients who have previously undergone liver transplantation can be a clinical challenge. There are serious concerns among physicians regarding the use of biologics for treating such immuno-compromised patients. OBJECTIVE: We performed a sy...
Spremljeno u:
| Izdano u: | United European Gastroenterol J |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6683639/ https://ncbi.nlm.nih.gov/pubmed/31428411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640619858050 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|